AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. STOK
  4. [EFFECT] Stoke Therapeutics, Inc. SEC Filing

[EFFECT] Stoke Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:00 P.M.
Form: S-3
CIK: 0001623526
Company Name: Stoke Therapeutics, Inc.
File Number: 333-288583

Source:

Stock STOK logo
Stoke Therapeutics

NASDAQ:STOK

STOK Rankings

#2709 Ranked by Market Cap
N/A Ranked by Dividends

STOK Latest News

Aug 12, 2025
Stoke Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates
Aug 7, 2025
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2025 Business and Financial Updates
Aug 6, 2025
Stoke Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference
Jul 16, 2025
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 17, 2025
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

STOK Latest SEC Filings

Aug 15, 2025
[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity
Aug 14, 2025
[SCHEDULE 13G/A] Stoke Therapeutics, Inc. SEC Filing
Aug 13, 2025
[144] Stoke Therapeutics, Inc. SEC Filing
Aug 12, 2025
[10-Q] Stoke Therapeutics, Inc. Quarterly Earnings Report
Aug 12, 2025
[8-K] Stoke Therapeutics, Inc. Reports Material Event

STOK Stock Data

926.62M
52.07M
4.57%
110.19%
21.06%
Biotechnology
Pharmaceutical Preparations
United States
BEDFORD